DAWNRAYS PHARMA: NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDER - NOTICE OF PUBLICATION OF 2023 ANNUAL REPORT, CIRCULAR, NOTICE OF ANNUAL GENERAL MEETING AND PROXY FORM
DAWNRAYS PHARMA: NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2023 ANNUAL REPORT, CIRCULAR, NOTICE OF ANNUAL GENERAL MEETING AND PROXY FORM
DAWNRAYS PHARMA: NOTIFICATION LETTER TO NON-REGISTERED HOLDER - NOTICE OF PUBLICATION OF 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
DAWNRAYS PHARMA: NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
DAWNRAYS PHARMA: 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
DAWNRAYS PHARMA: Form of proxy for use at the Annual General Meeting of the Company to be held on Friday, 24 May 2024 (or at any adjournment thereof)
DAWNRAYS PHARMA: NOTICE OF ANNUAL GENERAL MEETING
DAWNRAYS PHARMA: PROPOSALS FOR GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES; RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
DAWNRAYS PHARMA: 2023 ANNUAL REPORT
DAWNRAYS PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
DAWNRAYS PHARMA: (Updated) FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2023 AND CLOSURE OF REGISTER OF MEMBERS
DAWNRAYS PHARMA: FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2023 AND CLOSURE OF REGISTER OF MEMBERS
DAWNRAYS PHARMA: ANNOUNCEMENT OF THE ANNUAL RESULTS FOR THE YEAR ENDED 31 DECEMBER 2023
DAWNRAYS PHARMA: DATE OF BOARD MEETING
DAWNRAYS PHARMA: SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE DISPOSAL OF INTERESTS IN A JOINT VENTURE COMPANY
DAWNRAYS PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
DAWNRAYS PHARMA: DISCLOSEABLE TRANSACTION-DISPOSAL OF INTERESTS IN A JOINT VENTURE COMPANY
DAWNRAYS PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024
DAWNRAYS PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023
DAWNRAYS PHARMA: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
No Data